Literature DB >> 24006405

Transplantation in follicular lymphoma: not "yes or no" but "whom and when".

Georg Hess, Ralf Georg Meyer.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24006405      PMCID： PMC3762087          DOI： 10.3324/haematol.2013.091538

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  7 in total

Review 1.  The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular lymphoma: an evidence-based review.

Authors:  Denise M Oliansky; Leo I Gordon; Jerry King; Ginna Laport; John P Leonard; Peter McLaughlin; Robert J Soiffer; Koen W van Besien; Michael Werner; Roy B Jones; Philip L McCarthy; Theresa Hahn
Journal:  Biol Blood Marrow Transplant       Date:  2010-01-28       Impact factor: 5.742

2.  High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS.

Authors:  Eric Deconinck; Charles Foussard; Noel Milpied; Philippe Bertrand; Patrick Michenet; Pascale Cornillet-LeFebvre; Martine Escoffre-Barbe; Herve Maisonneuve; Vincent Delwail; Remy Gressin; Eric Legouffe; Jean-Pierre Vilque; Bernard Desablens; Jerome Jaubert; Jean-François Ramee; Arash Jenabian; Antoine Thyss; Annick Le Pourhiet-Le Mevel; Philippe Travade; Roselyne Delepine; Philippe Colombat
Journal:  Blood       Date:  2005-02-01       Impact factor: 22.113

3.  High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial.

Authors:  Harry C Schouten; Wendi Qian; Stein Kvaloy; Adolfo Porcellini; Hans Hagberg; Hans Erik Johnsen; Jeanette K Doorduijn; Matthew R Sydes; Gunnar Kvalheim
Journal:  J Clin Oncol       Date:  2003-09-29       Impact factor: 44.544

4.  The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT.

Authors:  S P Robinson; C Canals; J J Luang; H Tilly; C Crawley; J Y Cahn; D Pohlreich; S Le Gouill; M Gilleece; N Milpied; M Attal; P Biron; S Maury; A Rambaldi; J Maertens; S Capria; P Colombat; S Montoto; A Sureda
Journal:  Bone Marrow Transplant       Date:  2013-06-17       Impact factor: 5.483

5.  Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage.

Authors:  Marco Ladetto; Federica De Marco; Fabio Benedetti; Umberto Vitolo; Caterina Patti; Alessandro Rambaldi; Alessandro Pulsoni; Maurizio Musso; Anna M Liberati; Attilio Olivieri; Andrea Gallamini; Enrico Pogliani; Delia Rota Scalabrini; Vincenzo Callea; Francesco Di Raimondo; Vincenzo Pavone; Alessandra Tucci; Sergio Cortelazzo; Alessandro Levis; Mario Boccadoro; Ignazio Majolino; Alessandro Pileri; Alessandro M Gianni; Roberto Passera; Paolo Corradini; Corrado Tarella
Journal:  Blood       Date:  2008-01-31       Impact factor: 22.113

6.  Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group.

Authors:  Georg Lenz; Martin Dreyling; Eva Schiegnitz; Roswitha Forstpointner; Hannes Wandt; Mathias Freund; Georg Hess; Lorenz Truemper; Volker Diehl; Martin Kropff; Michael Kneba; Norbert Schmitz; Bernd Metzner; Markus Pfirrmann; Michael Unterhalt; Wolfgang Hiddemann
Journal:  Blood       Date:  2004-07-06       Impact factor: 22.113

7.  Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party.

Authors:  Silvia Montoto; Paolo Corradini; Martin Dreyling; Michele Ghielmini; Eva Kimby; Armando López-Guillermo; Stephen Mackinnon; Robert E Marcus; Gilles Salles; Harry C Schouten; Anna Sureda; Peter Dreger
Journal:  Haematologica       Date:  2013-07       Impact factor: 9.941
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.